Health Condition 1: N329- Bladder disorder, unspecified Health Condition 2: N329- Bladder disorder, unspecified Health Condition 3: N399- Disorder of urinary system, unspecified Health Condition 4: O- Medical and Surgical
Conditions
Interventions
Intervention1: AL group(Alkalinised Lignocaine+Lidocaine gel): Group A (AL group): In this group, patients will receive 10 ml of Lidocaine gel. 30 ml of the Alkalinised Lignocaine (AL) solution (Alkal
Sponsors
All India Institute of Medical Sciences Bhubaneswar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years or above undergoing cystoscopy(CPE) for following conditions- Check cystoscopy in Ca bladder patients in follow up, CPE for LUTS under evaluation and CPE for hematuria under evaluation 2. Written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients not giving consent. 2. Neurological disease that may affect bladder function/sensation (mainly MS). 3. Serious concomitant illness. 4. Patients with known drug allergy to local anesthetic drugs. 5. Patients with severe cardiovascular compromise.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare pain scores (100 mm Visual Analogue Scale score) amongst patients undergoing cystoscopy under Intravesical alkalinised lidocaine solution plus Lidocaine gel vs Lidocaine gel alone.Timepoint: 0 hour AND 1 hour | — |
Secondary
| Measure | Time frame |
|---|---|
| b) To compare the incidence of UTI- The participant will be contacted 1 week after and asked about symptoms of UTI: Dysuria, cloudy urine, pollakiuria, nocturia.Timepoint: 1 week;To compare patient tolerance as assessed by surgeon on 100 mm Visual Analogue Scale score.Timepoint: 0 hour;To compare postoperative complications: voiding difficulty and hematuria.Timepoint: 0 hour, 1 hour and 1 week;To compare the participant experience with the procedureTimepoint: 1 week | — |
Countries
India
Contacts
Public ContactKirti Singh
AIIMS, Bhubaneswar
Outcome results
None listed